Noveris Health Sciences Inc. (MYCOF)
OTC
0.7300
0.00 (0.00%)
Closed
Sep 24, 2026
Day's Range
0.73000.8000
52 wk Range
0.09602.04
Financial Statements - MYCOF - Noveris Health Sciences Inc.
Revenue
0
Net Income
2.92M▲ 192.7%
EBITDA
-961.05K▲ 59.7%
Free Cash Flow
9.37K▲ 125.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 7.49K | 2.61K |
| Cost of Goods | - | - | - | 0 | 0 | 0 |
| Gross Profit | - | - | - | 0 | 7.49K | 2.61K |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -549.93K | -2.53M | -9.54M | -15.97M | -22.68M | -11.45M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 3.68M | 828.44K | -10.09M | 1.13M | -693.50K | -15.23M |
| Pre Tax Income | 2.92M | -3.15M | -20.94M | -15.74M | -23.58M | -26.87M |
| Income Tax | - | - | - | - | - | - |
| Net Income | 2.92M | -3.15M | -20.94M | -9.24M | -28.89M | -26.94M |
| EPS Basic | 2.37 | -0.05 | -0.68 | -1.07 | -6.17 | -12.05 |
| EPS Diluted | 2.37 | -0.05 | -0.68 | -1.07 | -6.17 | -12.05 |
| Basic Shares Outstanding | 1.23M | 59.62M | 30.69M | 12.68M | 6.86M | 3.33M |
| Diluted Shares Outstanding | 1.23M | 59.62M | 30.69M | 12.68M | 6.86M | 3.33M |
| Ebit | 3.13M | -1.70M | -19.64M | -14.83M | -23.37M | -26.69M |
| Ebitda | -961.05K | -2.38M | -13.26M | -16.14M | -22.83M | -11.42M |
| Net Income Continuous Operations | 2.92M | -3.15M | -20.94M | -15.74M | -23.58M | -26.87M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
